Physicians need to be knowledgeable about both the potential benefits and possible harms of early screening and detection. What should we do when a healthy patient comes to our office requesting a full-body CT scan, genetic testing for cancer markers, or other screening measures that may not be suitable for their condition? How can we put health risks into perspective and give our patients basic information about the overdiagnosis and unnecessary treatment that may follow screening? For an interesting discussion about these questions and much more, host Dr. Jennifer Shu welcomes Dr. H. Gilbert Welch, professor of medicine and community and family medicine at Dartmouth Medical School, and author of Should I Be Tested for Cancer? Maybe Not, and Here's Why.
Preventive Medicine: Are We Taking It Too Far?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Physicians need to be knowledgeable about both the potential benefits and possible harms of early screening and detection. What should we do when a healthy patient comes to our office requesting a full-body CT scan, genetic testing for cancer markers, or other screening measures that may not be suitable for their condition? How can we put health risks into perspective and give our patients basic information about the overdiagnosis and unnecessary treatment that may follow screening? For an interesting discussion about these questions and much more, host Dr. Jennifer Shu welcomes Dr. H. Gilbert Welch, professor of medicine and community and family medicine at Dartmouth Medical School, and author of Should I Be Tested for Cancer? Maybe Not, and Here's Why.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
Updates From the 7th World Symposium Task Force
Chemotherapy Strategies for Metastatic PDAC
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
A Practical Guide to Prescribing in HF
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?